AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

RecruitingNAAges 60 Years - anyAllCentre Hospitalier Universitaire de Nice
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder. This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant. The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention. In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the interven

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Man or Woman aged \> 60 years 2. Have a minor neurocognitive disorder according to the criteria of the DSM 5 3. Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009). 4. Subject able to read and write French; 5. Subject beneficiaries of a social security scheme; 6. Ability to understand and sign free and informed consent. Exclusion Criteria: 1. Subject already practicing meditation and/or yoga and/or Tai Chi 2. Subject currently undergoing psychological therapy (whatever the approach) 3. Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments; 4. Presence and/or recent history (within the last 5 years prior to inclusion in the study) of major psychiatric disorders (e.g., schizophrenia, severe depression, addiction, bipolar disorders, psychotic disorders, risk of dissociation, panic attack, generalized anxiety disorder, etc.) 5. If taking psychotropic treatment, the dose must have been stable for 4 weeks 6. Vulnerable persons are defined in Articles L1121-5 to -8
๐Ÿ’Š

What it tests

  • cognitive stimulation
  • mixed intervention
๐Ÿ“

Where

1 site
CHU de Nice
Nice, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy